EIF6 and hepatocellular carcinoma: In this work, we asked whether three recently identified antagonists of the binding of eIF6 to the 60S ribosome, eIFsixty-1, eIFsixty-4 and eIFsixty-6, have an inhibitory activity on HCC spheroids that is comparable to genetic inhibition of eIF6.